Efficacy of novel agents in r/r T pro-lymphocytic leukaemia
Efficacy of novel agents in r/r T pro-lymphocytic leukaemia
Isatuximab in combination to treat relapsed/refractory MM
Single cell profiling reveals key differences in architecture of stem and progenitor cells throughout life
Development of a risk stratifying prognostic index for ALL
Specification of haematopoetic stem cell fate via modulation of mitochondrial activity
Onset and treatment of infantile leukaemia
Novel CD22 CAR-T therapy for paediatric leukaemia
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia
EHA Topics in focus : Immunotherapy
Novel ADC for relapsed/refractory lymphoma
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
Updated results from a phase I trial of CAR-T cell therapy for r/rMM